Mylan Labs

Mylan's Struggles Continue in the First Quarter
Motley Fool
Tue, 05/7/19 - 06:49 pm
Mylan Labs
earnings
Mylan, Biocon copy inches closer to challenging Sanofi's long-suffering Lantus
Fierce Pharma
Thu, 12/13/18 - 12:24 pm
Sanofi
Lantus
Eli Lilly
Boehringer Ingelheim
Mylan Labs
generics
diabetes
insulin
basal insulin
Mylan and Pfizer report new issues affecting some EpiPens that can delay treatment
Fierce Pharma
Sat, 11/3/18 - 04:12 pm
Mylan Labs
Pfizer
EpiPens
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
RAPS.org
Mon, 10/22/18 - 05:17 pm
Europe
AbbVie
Humira
Amgen
Samsung Bioepis
Mylan Labs
Novartis
Sandoz
Fresenius Kabi
Boehringer Ingelheim
Merck ditches biosimilar Lantus, but will that ease the path for Mylan’s rival insulin product?
Fierce Pharma
Fri, 10/12/18 - 12:47 pm
Merck
Samsung Bioepis
Lantus
insulin
diabetes
biosimilars
Mylan Labs
Biocon
Mylan Pharmaceuticals Pledges to Resolve FDA Citations Over Quality Control Failures
RAPS.org
Thu, 10/11/18 - 11:00 pm
Mylan Labs
drug manufacturing
FDA
Moody's picks 5 early winners in biosimilar market
Biopharma Dive
Fri, 10/5/18 - 09:01 pm
biosimilars
Pfizer
Biogen
Novartis
Amgen
Mylan Labs
Mylan secretly maneuvered to suppress evidence in EpiPen suit, plaintiffs say
Fierce Pharma
Wed, 10/3/18 - 06:48 pm
Mylan Labs
Pfizer
EpiPens
Mylan and Novartis to FDA: Where are the Suffixes?
RAPS.org
Wed, 09/26/18 - 07:23 pm
Mylan Labs
Novartis
drug names
biosimilars
biologics
Could troubled Mylan swing a sale to private equity buyer? One analyst thinks so
Fierce Pharma
Fri, 09/21/18 - 10:33 pm
Mylan Labs
M&A
Mylan, Fujifilm score EU thumbs-up for Humira biosimilar, putting more pressure on AbbVie
Forbes
Thu, 09/20/18 - 11:50 am
AbbVie
Mylan Labs
Fujifilm
biosimilars
Humira
With EpiPen competitors bearing down, can Mylan maintain its lead?
Fierce Pharma
Tue, 09/18/18 - 04:30 pm
Mylan Labs
EpiPens
ephinephrine autoinjectors
Kaleo
Auvi-Q
Mylan launches generic Brevibloc heart injection
Drug Delivery Business News
Thu, 09/13/18 - 11:18 pm
Mylan Labs
generics
Baxter
Brevibloc
Mylan Strikes $463 Million Deal With Novartis for CF Product Line
BioSpace
Fri, 09/7/18 - 11:03 am
Mylan Labs
Novartis
cystic fibrosis
EpiPen class action lawsuit against Mylan, Pfizer to continue, judge rules
Biopharma Dive
Tue, 08/21/18 - 07:31 pm
Pfizer
Mylan Labs
generics
EpiPens
antitrust
Mylan to explore its options as North American business struggles
Biopharma Dive
Thu, 08/9/18 - 07:53 am
Mylan Labs
Mylan lowers outlook after Q2 earnings, sales miss estimates
Drug Delivery Business News
Wed, 08/8/18 - 10:02 am
Mylan Labs
earnings
Pfizer says shortage of adult-dose EpiPens in Canada will persist through August
Fierce Pharma
Tue, 07/31/18 - 07:10 pm
EpiPens
Mylan Labs
Pfizer
drug shortage
drug manufacturing
Will Mylan’s big Copaxone price break force Teva’s hand? Clients are pushing already
Fierce Pharma
Mon, 07/16/18 - 11:29 am
Mylan Labs
Copaxone
generics
Teva Pharmaceuticals
MS
drug pricing
Mylan plant slapped with 32-page FDA Form 483
Fierce Pharma
Mon, 07/2/18 - 10:41 pm
Mylan Labs
FDA
drug manufacturing

Pages